Suchergebnisse - "Nuñez, Ivette A."

PubPharm (17)

1

Treatment of highly virulent mammarenavirus infections-status quo and future directions

enthalten in: Expert opinion on drug discovery | 2024

von Nuñez, I. | Crane, A. | Crozier, I. | +2

2

Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1

enthalten in: Frontiers in veterinary science | 2023

von Nuñez, I. | Jang, H. | Huang, Y. | +2

3

SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity

enthalten in: bioRxiv.org | 2021

von Nuñez, I. | Lien, C. | Selvaraj, P. | +4

4

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

enthalten in: NPJ vaccines | 2021

von Meseda, C. | Stauft, C. | Selvaraj, P. | +6

5

Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections

enthalten in: Pathogens (Basel, Switzerland) | 2021

von Nuñez, I. | Huang, Y. | Ross, T.

6

SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection

enthalten in: mSphere | 2021

von Nuñez, I. | Lien, C. | Selvaraj, P. | +4

UpdateOf: bioRxiv. 2021 Apr 02;:. - PMID 33821266

7

The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13

enthalten in: Journal of virology | 2021

von Liu, S. | Selvaraj, P. | Lien, C. | +4

8

SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters

enthalten in: Life science alliance | 2021

von Selvaraj, P. | Lien, C. | Liu, S. | +8

9

SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity

enthalten in: bioRxiv : the preprint server for biology | 2021

von Nuñez, I. | Lien, C. | Selvaraj, P. | +4

UpdateIn: mSphere. 2021 Jun 16;:e0050721. - PMID 34133199

10

Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses

enthalten in: Vaccine | 2021

von Bertran, K. | Kassa, A. | Criado, M. | +8